↓
 

ParagraphFour.com

Pharmaceutical Patent Database

ParagraphFour.com
  • Home
  • About
  • Paragraph IV Explained
  • FAQ & Terms
  • The PIV Book
  • The PIV Blog
  • PIV Data
    • Get Access
Home→parryashford

parryashford

Profile picture of parryashford

@parryashford

Active 6 days, 18 hours ago
  • Activity
  • Profile
  • Forums
  • Personal
  • Mentions
  • Favorites

Member Activities

RSS Feed

Loading the member’s updates. Please wait.

    Login

    Log In

    Latest updates

    Symtuza®(darunavir, cobicistat, emtricitabine, tenofovir alafenamide) Tablets
    Annual Sales $331M
    Company GILEAD
    Date of First Filing August 16, 2021

    Paragraph IV Applicant: Lupin
    Case Name: GILEAD SCIENCES INC v. LUPIN LTD
    Court/Case #: Delaware District Court (dedc) 1:2021cv01615
    Date Filed: 11/15/21
    Judge: Noreika
    Product…Read more

    Profile picture of parryashford 1 week, 4 days ago

    Nerlynx®(neratinib) Tablets
    Annual Sales $196M
    Company PUMA BIOTECHNOLOGY
    Date of First Filing July 19, 2021

    Paragraph IV Applicant: Sandoz
    Case Name: PUMA BIOTECHNOLOGY INC et al v. SANDOZ INC
    Court/Case #: New Jersey District Court (njdc) 3:2021cv19918
    Date Filed: 11/10/21
    Judge: Bumb
    Product Strength: 40 mg
    Litigated Patents…Read more

    Profile picture of parryashford 2 weeks, 3 days ago

    Exparel®(bupivicaine) Injectable Suspension
    Annual Sales $490M
    Company PACIRA
    Date of First Filing August 20, 2021

    Paragraph IV Applicant: eVenus
    Case Name: PACIRA PHARMACEUTICALS INC et al v. EVENUS PHARMACEUTICALS LABORATORIES INC et al
    Court/Case #: New Jersey District Court (njdc) 2:2021cv19829
    Date Filed: 11/8/21
    Judge: Ar…Read more

    Profile picture of parryashford 2 weeks, 5 days ago
    The Paragraph Four Report®, ParagraphFour.com® and the PFOUR logo are registered trademarks of Parry Ashford Inc. • ©Parry Ashford Inc. 2021
    ↑